Fibroblast-derived MDK promotes Lymph node metastasis in Luminal Breast Cancer through an SDC4-USP9X-RELB deubiquitination axis
BACKGROUND: Lymph node metastasis (LNM) is central to breast cancer staging and treatment decisions. Clinical observations indicate that luminal or hormone receptor-positive breast cancer may show a distinct clinical pattern of regional lymph node involvement, but the stromal and intracellular mechanisms remain unclear. METHODS: We integrated Surveillance, Epidemiology, and End Results (SEER) data, a multicenter institutional cohort, public single-cell RNA sequencing data, spatial transcriptomics, and multiplex immunofluorescence. Fibroblast states and candidate cell-cell communication pathways were examined using CytoTRACE, pseudotime, and ligand-receptor analyses. Functional and mechanistic validation included co-culture and Transwell assays, a mouse footpad-popliteal lymph node metastasis model, immunoprecipitation-mass spectrometry, co-immunoprecipitation, protein stability assays, and ubiquitination assays. Group comparisons used parametric or nonparametric tests, as appropriate. RESULTS: The SEER and multicenter cohorts showed a higher proportion of lymph node involvement in HR-positive/HER2-negative breast cancer than in the HER2-positive and triple-negative groups. Single-cell analysis identified a TINAGL1 + CAF population enriched in lymph node metastases, and spatial analysis demonstrated its proximity to epithelial tumor cells. Ligand-receptor analysis and tissue imaging supported MDK-SDC4 as a candidate stromal-tumor communication axis. Fibroblast-derived MDK promoted tumor-cell migration and invasion, and these responses were attenuated by SDC4 knockdown. Mechanistically, SDC4 associated with RELB and regulated its ubiquitination and proteasomal stability. USP9X associated with SDC4 and RELB, and USP9X perturbation altered RELB ubiquitination and protein stability. In vivo, SDC4 knockdown and overexpression produced opposite changes in imaging signals and popliteal lymph node volume, while RELB or USP9X knockdown attenuated the phenotype associated with SDC4 overexpression. Histological and immunohistochemical examination provided additional tissue-level characterization of the lymph node lesions. CONCLUSIONS: Fibroblast-derived MDK promotes breast cancer cell migration and invasion through tumor-cell SDC4. In vitro and in vivo findings support an SDC4-USP9X-RELB regulatory axis involving RELB ubiquitination and stability, providing mechanistic insight into stromal-tumor communication in regional lymph node metastasis.
Authors
- Shengbin Pei (ORCID: https://orcid.org/0009-0004-1086-3595)
- Wangzheqi Zhang (ORCID: https://orcid.org/0009-0008-5312-1806)
- Zheng Li (ORCID: https://orcid.org/0000-0002-8837-0318)
- Ye Lu (ORCID: https://orcid.org/0009-0003-2703-5879)
- Yiqin Xia (ORCID: https://orcid.org/0000-0002-2297-2471)
- Zheng Qu (ORCID: https://orcid.org/0000-0002-4455-8466)
- Luxiao Zhang
- Hongzhe Zhang
- Lei Sun
- Xue Yang
- Jing Wang
Institutions
- Shandong University of Traditional Chinese Medicine (CN)
- Second Military Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Cancer Hospital of Chinese Academy of Medical Sciences (CN)
- Jiangsu Province Hospital (CN)
- University of Pennsylvania (US)
Publication Details
- Journal
- Experimental Hematology and Oncology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1186/s40164-026-00865-2
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science and Technology Major Project